Reports >
Life Sciences
>
Biological Safety Testing Market Report
Biological Safety Testing Market Report
First published: 10 October 2024 | Last updated: 25 May 2026 | Report Code: biological-safety-testing
Biological Safety Testing Market — USD 5.6 billion in 2023, Growing to USD 11.01B by 2033 at 6.8% CAGR
This report provides a detailed analysis of the Biological Safety Testing market, including insights on market size, regional performance, industry trends, and future forecasts for the period 2023 to 2033.
Key Takeaways
- Global market expands from $5.60 Billion in 2023 to $11.01 Billion by 2033, reflecting a 6.8% CAGR.
- North America is largest regional market, while no single fastest-growing region is stated because regional CAGR differences remain within 0.15 percentage points.
- Europe grows from $1.44 Billion in 2023 to $2.82 Billion in 2033, supported by regulatory requirements and R&D activity.
- Asia Pacific advances from $1.20 Billion in 2023 to $2.36 Billion in 2033 amid rising biotech investments and testing demand.
- Key service areas include microbial testing, biocompatibility testing, and viral safety testing, with major firms such as SGS S.A., Charles River Laboratories, Eurofins Scientific, and LGC Group.
Biological Safety Testing Market Report — Executive Summary
North America remains largest market by forecast-period value, while no single fastest-growing region is stated because top regional growth rates are separated by less than 0.15 percentage points. The Biological Safety Testing market is projected to grow from $5.60 Billion in 2023 to $11.01 Billion by 2033 at a 6.8% CAGR during 2023 to 2033. Growth is driven by stricter regulatory oversight, increasing biotechnology and pharmaceutical R&D, and heightened emphasis on patient safety through microbial, biocompatibility, and viral testing. North America stands as the largest regional market, rising from $1.96 Billion to $3.86 Billion over the forecast period. Europe and Asia Pacific also show substantial expansion, reflecting demand for standardized testing procedures and investments in advanced testing technologies such as automation. Leading providers including SGS S.A., Charles River Laboratories, Eurofins Scientific, and LGC Group are focusing on service diversification and technology integration to improve throughput and reliability. The market landscape is shaped by complex regulation, growing cross-border testing needs, and ongoing innovation in bioanalytical methods that reduce turnaround times and increase testing accuracy.
Key Growth Drivers
- Tighter regulatory standards driving higher demand for validated safety testing services.
- Rising R&D investments by pharmaceutical and biotechnology firms increasing testing volume.
- Growing need for viral and microbial contamination screening across biologics and medical devices.
- Adoption of automation and digital tools to reduce test times and improve reproducibility.
- Expansion of standardized protocols and cross-border testing requirements supporting market expansion.
| Metric | Value |
|---|---|
| Study Period | 2023 - 2033 |
| 2023 Market Size | $5.60 Billion |
| CAGR (2023-2033) | 6.8% |
| 2033 Market Size | $11.01 Billion |
| Top Companies | SGS S.A., Charles River Laboratories, Eurofins Scientific, LGC Group |
| Published Date | 10 October 2024 |
| Last Modified Date | 25 May 2026 |
Biological Safety Testing Market Overview
Customize Biological Safety Testing Market Report market research report
- ✔ Get in-depth analysis of Biological Safety Testing market size, growth, and forecasts.
- ✔ Understand Biological Safety Testing's regional dynamics and industry-specific trends.
- ✔ Identify potential applications, end-user demand, and growth segments in Biological Safety Testing
What is the Market Size & CAGR of Biological Safety Testing Market Report market in 2023?
Biological Safety Testing Industry Analysis
Biological Safety Testing Market Segmentation and Scope
Tell us your focus area and get a customized research report.
Biological Safety Testing Market Report Market Analysis Report by Region
Europe Biological Safety Testing Market Report:
Europe grows from $1.44 Billion in 2023 to $2.82 Billion in 2033. 44 Billion in 2023 to $2.82 Billion in 2033, driven by regulatory oversight, investments in medical research, and the need for standardized testing across member states, which supports demand for microbial and biocompatibility services.Asia Pacific Biological Safety Testing Market Report:
Asia Pacific grows from $1.2 Billion in 2023 to $2.36 Billion in 2033. 20 Billion in 2023 to $2.36 Billion in 2033 as rising biotech investment, growing pharmaceutical manufacturing, and increasing awareness of product safety necessitate more viral and microbial testing capacity.North America Biological Safety Testing Market Report:
North America is largest regional market, rising from $1.96 Billion in 2023 to $3.86 Billion in 2033. Regional demand is fueled by extensive pharmaceutical and biotech R&D, strong regulatory frameworks, and established testing infrastructure supporting expanded safety services.South America Biological Safety Testing Market Report:
Latin America grows from $0.4 Billion in 2023 to $0.78 Billion in 2033. 40 Billion in 2023 to $0.78 Billion in 2033, with regional growth linked to expanding healthcare and pharmaceutical activities, and increasing emphasis on compliance and safety testing for locally produced and imported products.Middle East & Africa Biological Safety Testing Market Report:
Middle East and Africa grows from $0.6 Billion in 2023 to $1.19 Billion in 2033. 60 Billion in 2023 to $1.19 Billion in 2033, supported by growing healthcare infrastructure, higher demand for medical device and biologics testing, and investments in laboratory capabilities.Tell us your focus area and get a customized research report.
Research Methodology
Biological Safety Testing Market Analysis By Type
Microbial Testing accounted for a significant market size of approximately $3.69 billion in 2023, projected to reach $7.26 billion by 2033. This segment represents 65.97% market share, driven by the high demand for microbial control in pharmaceuticals. Biocompatibility Testing, currently valued at $1.60 billion, is expected to grow to $3.14 billion (28.57% share). Viral Safety Testing, while smaller, remains essential, with insights projecting growth from $0.31 billion to $0.60 billion.
Biological Safety Testing Market Analysis By Industry
The segment includes Pharmaceuticals, which leads with a market size of $3.69 billion expected to rise to $7.26 billion by 2033, and is indicative of the industry's reliance on safety testing protocols due to regulatory requirements. Medical Devices follow with a market size of $1.60 billion growing to $3.14 billion, representing vital compliance needs, while Biotechnology, currently at $0.31 billion, is also expected to scale up similarly, reaching $0.60 billion by 2033.
Biological Safety Testing Market Analysis By Region
The regional analysis emphasizes North America's dominance, forecasted to retain its leading position through 2033 due to strong investments in healthcare and safety measures. Europe and Asia Pacific follow closely behind, leveraging regulatory frameworks to bolster their growth perspectives. South America and Middle East & Africa provide emerging opportunities aligning with increased healthcare demands and safety assurances.
Biological Safety Testing Market Trends and Future Forecast
Tell us your focus area and get a customized research report.
Global Market Leaders and Top Companies in Biological Safety Testing Industry
SGS S.A.:
SGS S.A. is a global leader in inspection, verification, testing, and certification, providing biological safety testing services that cater to various industries. Their commitment to quality and innovation makes them a trusted partner for product safety.Charles River Laboratories:
As a renowned entity in preclinical and clinical laboratory services, Charles River Laboratories offers extensive biological safety testing solutions crucial for the development of new pharmaceuticals and medical devices.Eurofins Scientific:
Eurofins is a global group of laboratories that provides innovative biosafety testing services, serving the pharmaceutical and biopharmaceutical sectors, with a strong emphasis on high-quality processes and customer satisfaction.LGC Group:
LGC is known for its comprehensive biological safety testing services and high standards of quality and accuracy, ensuring products meet regulatory requirements efficiently.We're grateful to work with incredible clients.
FAQs
What is the market size of the Biological Safety Testing Market Report in 2023?
The market size in 2023 is $5.60 Billion, as stated in the report's baseline year figure for the global market.
What is the forecasted market size for 2033?
The projected market size for 2033 is $11.01 Billion according to the provided ten-year outlook.
What is CAGR of the market during the forecast period?
The Compound Annual Growth Rate for the forecast period 2023 to 2033 is 6.8% as specified in the input data.
Is there a single fastest Growing region in the Biological Safety Testing Market Report market?
No single fastest-growing region is stated for the Biological Safety Testing Market Report market because the top regional implied CAGR values are within 0.15 percentage points of each other, making the ranking too close to call reliably.
Which companies are listed as top providers?
Top companies identified include SGS S.A., Charles River Laboratories, Eurofins Scientific, and LGC Group in the market overview.
Why is the Biological Safety Testing market growing?
Growth is attributed to stricter regulations, increased biotech and pharmaceutical R&D, and higher demand for microbial and viral safety testing services.
What are the primary service segments in the market?
Primary service segments include microbial testing, biocompatibility testing, and viral safety testing as noted in the segment facts.
How is regional growth described overall?
Regional growth figures are provided for each region with North America as the largest; no single regional market region is named per the input policy.